EN | UA
EN | UA

Help Support

Back

Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety

Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety
Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety

The scarcity of the approved curative agents for coronavirus disease (COVID-19) has led to a fast implementation of convalescent plasma therapy (CPT) in several countries. 

See All

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ua en ru
Try: